Tauriga Sciences Inc. Introduces Innovative New Product Offering, Exclusively Available on Company’s E-Commerce Website - Super Deluxe Rainbow Pack @ $136.99 Each

Rhea-AI Summary

Tauriga Sciences (OTCQB: TAUG) announced the launch of its Super Deluxe Rainbow Pack, featuring nine Tauri-Gum SKUs and a 10th Mystery Flavor. The company will donate $3 from each pack to charity, aiming to boost future e-commerce sales. The original Rainbow Pack, launched in September 2020, has been successful in the market. Pre-orders will commence this week on the company's e-commerce website. Additionally, Tauriga is developing a pharmaceutical-grade Tauri-Gum for chemotherapy-related nausea, having filed a non-provisional patent application.

Positive

• Launch of Super Deluxe Rainbow Pack, expected to enhance e-commerce sales.
• Successful history with the original Rainbow Pack since September 2020.
• Charitable contribution of $3 from each Pack sold.

Negative

• None.

NEW YORK, NY, June 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a New York based diversified Life Sciences Company, today introduced the Company’s Super Deluxe Rainbow Pack (“Super Pack” or “Pack”), which is comprised of 1 Blister Pack (each of the 9 Tauri-Gum SKUs).  Each Pack will also include a 10^thBlister Pack “Mystery Flavor” and a limited Edition (intricately designed) dedicated retail box tray.  The Company will contribute $3 from each Pack sold, to various charitable causes.   The Company expects to launch this Super Pack during mid-June 2021 and believes that it will drive future E-Commerce sales growth.   The original Rainbow Pack, launched during September 2020, was highly successful and has continually been popular with E-Commerce customers.  

The Company will be accepting Pre-Orders later this week, on its E-Commerce Website (www.taurigum.com) 

Super Deluxe Rainbow Pack:

1 Blister Pack 25mg CBD Mint Flavor

1 Blister Pack 25mg CBD Blood Orange Flavor

1 Blister Pack 25mg CBD Pomegranate Flavor

1 Blister Pack 25mg CBG Peach-Lemon Flavor

1 Blister Pack 25mg CBG Black Currant Flavor

1 Blister Pack 60mg Vitamin C + 10mg Zinc Pear Bellini Flavor

1 Blister Pack 50mg Caffeine Cherry Lime Rickey Flavor

1 Blister Pack 2000 IU Vitamin D3 Golden Raspberry Flavor

1 Blister Pack 10mg Delta 8 THC Evergreen Mint Flavor

1 Blister Pack “Bonus / Mystery” Flavor

And 

1 Limited Edition Retail Box Tray

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant), (Vitamin C + Zinc Infused Tauri-Gum™ Flavor: Pear Bellini), (Caffeine Infused Tauri-Gum™ Flavor: Cherry Lime Rickey), & (Vitamin D3 Infused Tauri-Gum™ Flavor: Golden Raspberry).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com 

Complementary to the Company’s retail business, is its ongoing Pharmaceutical Development initiative.  This relates to the development of a proposed Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed for the following indication: Patients Subjected to Ongoing Chemotherapy Treatment). On March 22, 2021, the Company announced that it had Converted its U.S. Provisional Patent Application (filed on March 17, 2020) into a U.S. Non-Provisional Patent Application.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”.  On December 18, 2020 the Company disclosed that it had entered into a Master Services Agreement with CSTI to lead the Company's clinical development efforts.

The Company is headquartered in Wappingers Falls, New York.  In addition, the Company operates two full time E-Commerce fulfillment centers: one located in Montgomery, Texas and the other in Brooklyn, New York.

DISCLAIMER -- Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other periodic filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

Contact:

Tauriga Sciences, Inc.

4 Nancy Court, Suite 4

Wappingers Falls, NY 12590

Chief Executive Officer

Mr. Seth M. Shaw

Email: sshaw@tauriga.com

cell # (917) 796 9926

Company Instagram: @taurigum

Personal Instagram: @sethsms47

Twitter: @SethMShaw

Corp. Website:   www.tauriga.com

E-Commerce Website:  www.taurigum.com

Attachment

• June 1st PR Image

FAQ

What is in the Super Deluxe Rainbow Pack by Tauriga Sciences?

The Super Deluxe Rainbow Pack includes nine Tauri-Gum SKUs and a 10th Mystery Flavor, along with a limited edition retail box.

When will the Super Deluxe Rainbow Pack be available for pre-order?

Pre-orders for the Super Deluxe Rainbow Pack will begin later this week on the company's e-commerce website.

What is the price of the Super Deluxe Rainbow Pack?

The price of the Super Deluxe Rainbow Pack has not been specified in the press release.

What charitable causes will benefit from the Super Deluxe Rainbow Pack sales?

Tauriga Sciences will contribute $3 from each Super Deluxe Rainbow Pack sold to various charitable causes.

What is the purpose of Tauriga's pharmaceutical-grade Tauri-Gum?

Tauriga is developing a pharmaceutical-grade version of Tauri-Gum for regulating nausea, specifically for chemotherapy patients.